These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 21636254

  • 1. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
    Baloush-Kleinman V, Levine SZ, Roe D, Shnitt D, Weizman A, Poyurovsky M.
    Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
    Beck EM, Cavelti M, Kvrgic S, Kleim B, Vauth R.
    Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
    [Abstract] [Full Text] [Related]

  • 4. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder.
    Wong MM, Chen EY, Lui SS, Tso S.
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):135-41. PubMed ID: 21983497
    [Abstract] [Full Text] [Related]

  • 5. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D, Delgado A, Bouju S, Comet D, Chiariny JF.
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
    Yang J, Ko YH, Paik JW, Lee MS, Han C, Joe SH, Jung IK, Jung HG, Kim SH.
    Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
    [Abstract] [Full Text] [Related]

  • 8. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
    Brain C, Allerby K, Sameby B, Quinlan P, Joas E, Karilampi U, Lindström E, Eberhard J, Burns T, Waern M.
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nonadherence to antipsychotics: the role of positive attitudes towards positive symptoms.
    Moritz S, Hünsche A, Lincoln TM.
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1745-52. PubMed ID: 25444234
    [Abstract] [Full Text] [Related]

  • 12. Adherence styles of schizophrenia patients identified by a latent class analysis of the Medication Adherence Rating Scale (MARS): a six-month follow-up study.
    Jaeger S, Pfiffner C, Weiser P, Kilian R, Becker T, Längle G, Eschweiler GW, Croissant D, Schepp W, Steinert T.
    Psychiatry Res; 2012 Dec 30; 200(2-3):83-8. PubMed ID: 22534500
    [Abstract] [Full Text] [Related]

  • 13. Treatment adherence and insight in schizophrenia.
    Bitter I, Fehér L, Tényi T, Czobor P.
    Psychiatr Hung; 2015 Dec 30; 30(1):18-26. PubMed ID: 25867885
    [Abstract] [Full Text] [Related]

  • 14. Negative impact of self-stigmatization on attitude toward medication adherence in patients with psychosis.
    Uhlmann C, Kaehler J, Harris MS, Unser J, Arolt V, Lencer R.
    J Psychiatr Pract; 2014 Sep 30; 20(5):405-10. PubMed ID: 25226204
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
    Zhang C, Chen MJ, Wu GJ, Wang ZW, Rao SZ, Zhang Y, Yi ZH, Yang WM, Gao KM, Song LS.
    J Clin Psychiatry; 2016 Nov 30; 77(11):e1460-e1466. PubMed ID: 28076667
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Collaboration in outpatient antipsychotic drug treatment: analysis of potentially influencing factors.
    Klingberg S, Schneider S, Wittorf A, Buchkremer G, Wiedemann G.
    Psychiatry Res; 2008 Nov 30; 161(2):225-34. PubMed ID: 18922582
    [Abstract] [Full Text] [Related]

  • 18. Early perception of medication benefit predicts subsequent antipsychotic response in schizophrenia: "the consumer has a point" revisited.
    Ascher-Svanum H, Weiden P, Nyhuis AW, Faries DE, Stauffer V, Kollack-Walker S, Kinon BJ.
    Clin Schizophr Relat Psychoses; 2014 Jul 30; 8(2):84-90, 90A. PubMed ID: 23446198
    [Abstract] [Full Text] [Related]

  • 19. The influence of perceived social support on medication adherence in first-episode psychosis.
    Rabinovitch M, Cassidy C, Schmitz N, Joober R, Malla A.
    Can J Psychiatry; 2013 Jan 30; 58(1):59-65. PubMed ID: 23327758
    [Abstract] [Full Text] [Related]

  • 20. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
    Kao YC, Liu YP.
    Compr Psychiatry; 2010 Jan 30; 51(6):557-65. PubMed ID: 20965300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.